坚持吸入皮质类固醇与哮喘患者生活质量和焦虑、抑郁症状的关系

IF 1.8 Q3 RESPIRATORY SYSTEM
European Clinical Respiratory Journal Pub Date : 2022-11-24 eCollection Date: 2023-01-01 DOI:10.1080/20018525.2022.2149920
Martino Renzi-Lomholt, Kjell Erik Julius Håkansson, Charlotte Suppli Ulrik
{"title":"坚持吸入皮质类固醇与哮喘患者生活质量和焦虑、抑郁症状的关系","authors":"Martino Renzi-Lomholt,&nbsp;Kjell Erik Julius Håkansson,&nbsp;Charlotte Suppli Ulrik","doi":"10.1080/20018525.2022.2149920","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Poor asthma control, often caused by non-adherence with controller medication, is a well-known risk factor for impaired quality of life (QoL) and major mood disorders (MMD). Previous studies have shown a relationship between non-adherence, lower QoL, and MMD across chronic diseases, but the relationship remains uncertain in asthma.</p><p><strong>Methods: </strong>All asthma patients followed at the respiratory outpatient clinic at Copenhagen University Hospital - Hvidovre were invited to fill-in the Hospital Anxiety and Depression Scale (HADS) and the Mini Asthma Quality of Life Questionnaire (miniAQLQ). Medication Possession Ratio (MPR) was calculated using pharmacy redemption data. Relationships between questionnaire scores, inhaled corticosteroid MPR and use of rescue medication were investigated using Pearson correlation and multivariable linear regression adjusted for age, sex, FEV<sub>1</sub>, and GINA Step. Data from scheduled visits were collected from patients' medical records.</p><p><strong>Results: </strong>A total of 308 patients (73% females, median age 51 years (interquartile range (IQR) 37, 62)) completed the questionnaires and had 1-year medication data available. Median adherence to inhaled corticosteroids (ICS) was 57% (35%, 75%) with 18% of patients having adherence above 80%. Of the participating patients, 14% and 27% reported depressive and anxiety-related symptoms, respectively, and 72% reported impaired QoL. In correlation analyses, ICS adherence was not significantly associated with either prevalence of MMD symptoms or impaired QoL in asthma patients. However, a strong correlation was found between ACQ-6 and both MMD symptoms and impaired QoL, as well as between rescue medication use and impaired QoL. In adjusted analysis, however, the latter correlation was no longer statistically significant.</p><p><strong>Conclusion: </strong>Our results suggest that ICS adherence is not directly correlated with either impaired quality of life or major mood disorder symptoms in asthma patients. Self-reported asthma control, on the other hand, is strongly correlated with both QoL and MMD.</p>","PeriodicalId":11872,"journal":{"name":"European Clinical Respiratory Journal","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2022-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/5f/ZECR_10_2149920.PMC9704108.pdf","citationCount":"0","resultStr":"{\"title\":\"Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma.\",\"authors\":\"Martino Renzi-Lomholt,&nbsp;Kjell Erik Julius Håkansson,&nbsp;Charlotte Suppli Ulrik\",\"doi\":\"10.1080/20018525.2022.2149920\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Poor asthma control, often caused by non-adherence with controller medication, is a well-known risk factor for impaired quality of life (QoL) and major mood disorders (MMD). Previous studies have shown a relationship between non-adherence, lower QoL, and MMD across chronic diseases, but the relationship remains uncertain in asthma.</p><p><strong>Methods: </strong>All asthma patients followed at the respiratory outpatient clinic at Copenhagen University Hospital - Hvidovre were invited to fill-in the Hospital Anxiety and Depression Scale (HADS) and the Mini Asthma Quality of Life Questionnaire (miniAQLQ). Medication Possession Ratio (MPR) was calculated using pharmacy redemption data. Relationships between questionnaire scores, inhaled corticosteroid MPR and use of rescue medication were investigated using Pearson correlation and multivariable linear regression adjusted for age, sex, FEV<sub>1</sub>, and GINA Step. Data from scheduled visits were collected from patients' medical records.</p><p><strong>Results: </strong>A total of 308 patients (73% females, median age 51 years (interquartile range (IQR) 37, 62)) completed the questionnaires and had 1-year medication data available. Median adherence to inhaled corticosteroids (ICS) was 57% (35%, 75%) with 18% of patients having adherence above 80%. Of the participating patients, 14% and 27% reported depressive and anxiety-related symptoms, respectively, and 72% reported impaired QoL. In correlation analyses, ICS adherence was not significantly associated with either prevalence of MMD symptoms or impaired QoL in asthma patients. However, a strong correlation was found between ACQ-6 and both MMD symptoms and impaired QoL, as well as between rescue medication use and impaired QoL. In adjusted analysis, however, the latter correlation was no longer statistically significant.</p><p><strong>Conclusion: </strong>Our results suggest that ICS adherence is not directly correlated with either impaired quality of life or major mood disorder symptoms in asthma patients. Self-reported asthma control, on the other hand, is strongly correlated with both QoL and MMD.</p>\",\"PeriodicalId\":11872,\"journal\":{\"name\":\"European Clinical Respiratory Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2022-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/5f/ZECR_10_2149920.PMC9704108.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Clinical Respiratory Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/20018525.2022.2149920\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Clinical Respiratory Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20018525.2022.2149920","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:哮喘控制不佳,通常由不遵守控制药物引起,是众所周知的生活质量受损(QoL)和严重情绪障碍(MMD)的危险因素。先前的研究表明慢性疾病中不依从性、较低的生活质量和烟雾病之间存在关系,但在哮喘中的关系仍不确定。方法:对所有在哥本哈根大学附属Hvidovre医院呼吸内科门诊就诊的哮喘患者进行随访,填写医院焦虑抑郁量表(HADS)和迷你哮喘生活质量问卷(miniAQLQ)。使用药房赎回数据计算药物持有率(MPR)。采用Pearson相关和校正年龄、性别、FEV1和GINA Step的多变量线性回归,研究问卷得分、吸入皮质类固醇MPR和使用抢救药物之间的关系。预定访问的数据从患者的医疗记录中收集。结果:308例患者(女性73%,中位年龄51岁(四分位间距(IQR) 37,62))完成了问卷调查,并有1年用药资料。吸入皮质类固醇(ICS)的中位依从性为57%(35%,75%),18%的患者依从性高于80%。在参与研究的患者中,分别有14%和27%报告抑郁和焦虑相关症状,72%报告生活质量受损。在相关分析中,ICS依从性与哮喘患者烟雾病症状的患病率或生活质量受损均无显著相关性。然而,ACQ-6与烟雾病症状和生活质量受损之间,以及抢救用药与生活质量受损之间存在很强的相关性。然而,在调整分析中,后一种相关性不再具有统计学意义。结论:我们的研究结果表明,ICS依从性与哮喘患者的生活质量受损或主要情绪障碍症状均无直接关系。另一方面,自我报告的哮喘控制与生活质量和烟雾度密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma.

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma.

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma.

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma.

Background: Poor asthma control, often caused by non-adherence with controller medication, is a well-known risk factor for impaired quality of life (QoL) and major mood disorders (MMD). Previous studies have shown a relationship between non-adherence, lower QoL, and MMD across chronic diseases, but the relationship remains uncertain in asthma.

Methods: All asthma patients followed at the respiratory outpatient clinic at Copenhagen University Hospital - Hvidovre were invited to fill-in the Hospital Anxiety and Depression Scale (HADS) and the Mini Asthma Quality of Life Questionnaire (miniAQLQ). Medication Possession Ratio (MPR) was calculated using pharmacy redemption data. Relationships between questionnaire scores, inhaled corticosteroid MPR and use of rescue medication were investigated using Pearson correlation and multivariable linear regression adjusted for age, sex, FEV1, and GINA Step. Data from scheduled visits were collected from patients' medical records.

Results: A total of 308 patients (73% females, median age 51 years (interquartile range (IQR) 37, 62)) completed the questionnaires and had 1-year medication data available. Median adherence to inhaled corticosteroids (ICS) was 57% (35%, 75%) with 18% of patients having adherence above 80%. Of the participating patients, 14% and 27% reported depressive and anxiety-related symptoms, respectively, and 72% reported impaired QoL. In correlation analyses, ICS adherence was not significantly associated with either prevalence of MMD symptoms or impaired QoL in asthma patients. However, a strong correlation was found between ACQ-6 and both MMD symptoms and impaired QoL, as well as between rescue medication use and impaired QoL. In adjusted analysis, however, the latter correlation was no longer statistically significant.

Conclusion: Our results suggest that ICS adherence is not directly correlated with either impaired quality of life or major mood disorder symptoms in asthma patients. Self-reported asthma control, on the other hand, is strongly correlated with both QoL and MMD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
15
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信